MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

April 2006


Pharmaceutical Approval Update: Oncology

Dr. Goldenberg reviews cetuximab (Erbitux) combined with radiation therapy for cancer of the head and neck; sunitinib (Sutent) for gastrointestinal stromal tumors (GISTs) and advanced kidney cancer; and sorafenib tosylate (Nexavar) for advanced renal cell carcinoma.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

22nd Annual Meeting of the American Academy of Pain Medicine

The authors report on advances with morphine sulfate and oxymorphone for back pain, ziconotide for chronic pain, intranasal morphine and transdermal hydromorphone for postoperative pain, fentanyl tablets for cancer-related breakthrough pain, lower-dose epidural steroids for lumbar radiculopathy and spinal stenosis, and duloxetine for diabetic peripheral neuropathic pain.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Letter to the Editor

Drugs for Less: Still More Press

Continuing Education Credit

Principles of Epidemiology for Clinical and Formulary Management Professionals

The authors discuss the fundamentals of epidemiology in the context of cohort studies, case-control studies, and experimental studies (clinical trials) and describe the importance of epidemiology in making formulary decisions.
David D. Dore, PharmD, PhD Candidate, E. Paul Larrat, MBA, PhD, and F. Randy Vogenberg, RPh, PhD



Toot Your Horn

David Nash, MD, MBA, discusses the improvements being made in the quality of drug delivery by the Medication Quality Subcommittee at Thomas Jefferson University Hospital.
David Nash, MD, MBA

Medication Errors

Pain Scales Don’t Weigh Every Risk

Matthew Grissinger, RPh, FASCP, explains how noble efforts to manage pain in hospitals can inadvertently compromise patient safety.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

New FDA Commissioner to Face Vital Drug Safety Concerns: Companies Slow to Complete Postmarketing Trials

Stephen Barlas emphasizes the need for drug manufacturers to complete promised postmarketing (phase 4) trials in a timely way—this is just one of many challenges facing the new FDA Commissioner.
Stephen Barlas

Drug News

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Rituximab for Patients with Refractory Rheumatoid Arthritis

The authors review rituximab (Rituxan) for patients with refractory rheumatoid arthritis.
Patty Ghazvini, PharmD, Angela Singh, PharmD, Phillip Treadwell, PharmD, Marlon Honeywell, PharmD, and Natosha Canty, MD